C.R. Bard Inc. (NYSE:BCR) plans to cut 50 jobs from its Queensbury, N.Y.-based manufacturing plant.
The 50 positions could be relocated outside the U.S., according to the Glen Falls, N.Y.-based Post Star. That would leave the Queensbury plant with roughly 770 employees.
Abbott Laboratories (NYSE:ABT) is laying off a total of 160 jobs in its diagnostics operation, continuing a streamlining effort it launched in 2008.
The cuts include 10 jobs at the health care conglomerate’s Chicago headquarters and about 150 positions at a plant in Santa Clara, Calif., according to the Chicago Tribune.
Wright Medical Group Inc. (NSDQ:WMGI) is cutting 80 positions, or about 6 percent of its total workforce, in a move aimed at raising its earnings per share, the Arlington, Tenn.-based orthopedic device maker said today.
The plan, initially slated to roll out over the next nine months, will see Wright try to re-shape its international operations, scaling back the products it offers overseas and "streamlining select aspects of its international selling and distribution operations," according to a press release.
ARLINGTON, Tenn.–(BUSINESS WIRE)–Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical
device company and a leading provider of surgical solutions for the foot
and ankle market, announced today that it is implementing a cost
restructuring plan to foster growth, enhance profitability and cash
flow, and build shareholder value. Wright Medical expects that the
initial phase of this plan will be completed during the next nine
months, with additional efficiency initiatives to be implemented
throughout 2012 and beyond.
Medtronic Inc. (NYSE:MDT) is looking to eliminate about 700 more jobs by the end of its current fiscal year through layoffs and early retirement offers, according to regulatory documents.
The moves are part of a restructuring initiative the company announced in February to reduce its global workforce by 5 percent.
Officials at World Heart Corp. (NSDQ:WHRT) officially pulled the plug on clinical trials of the company’s Levacor ventricular assist device (VAD) technology and laid off nearly half its workforce.
Histogenics Corp., fresh from a merger with fellow Bay State firm Prochon Biotech, has no plans for layoffs, contrary to a report in an Israeli journal.
The Globes new outlet, a business daily based in Rishon Le-Zion, Israel, reported yesterday that Histogenics "will make substantial cuts" to its R&D unit in Ness Ziona.
Stryker Corp. (NYSE: SYK ) is cutting about 6 percent of its workforce in Ireland, according to news reports out of the Emerald Isle.
The RTE News service said the company will be consolidating two plants in the town of Carrigtwohill in the northeast section of the country, resulting in about 142 layoffs. Announcements were made in a series of meetings at the facilities, according to the news service.
It turns out the rumors were true: Minnesota-based employees of Boston Scientific Corp. (NYSE:BSX) began receiving pink slips this week.
Reports surfaced last month that the Natick, Mass.-based medical device giant was planning to lay off workers from its cardiology, rhythm and vascular business in the Twin Cities.
Medtronic Inc. (NYSE:MDT) shares are reversing a modest climb off a 4 percent decline that followed its announcement today that the device manufacturer intends to cut up 2,000 jobs over the next two months.
The Minneapolis-based company has not yet identfied where it intends to make the layoffs, but said it expects to complete the restructuring by the end of its fourth quarter that ends in April.
MassDevice Network
@MassDevice
LinkedIn
YouTube